Brief: Cstone Pharmaceuticals Announces Further Increase In Shareholding By CEO
09/04/2025 08:01
April 9 (Reuters) - CStone Pharmaceuticals 2616.HK: FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR CEO PURCHASED 560,000 SHARES FROM APRIL 2 TO 7 WITH PURCHASE PRICE PER SHARE RANGING FROM HKD2.26 TO HKD3.29 Further company coverage: 2616.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026